Carcinogenic risk of toluene diisocyanate and 4,4′-methylenediphenyl diisocyanate: Epidemiological and experimental evidence

Critical Reviews in Toxicology

Volumn 31, Issue 6, 2001, Pages 737-772

  Bolognesi, Claudia ^a   Baur, Xaver ^b   Marczynski, Boleslaw ^c   Norppa, Hannu ^d   Sepai, Ovnair ^e   Sabbioni, Gabriele ^f  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF HAMBURG   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cancer; DNA adducts; Epidemiology; Genotoxicity; Isocyanates; MDI; Protein adducts; TDI

Indexed keywords

CARCINOGEN; DIPHENYLMETHANE 4,4' DIISOCYANATE; TOLUENE DIISOCYANATE;

ACUTE TOXICITY; CANCER RISK; CARCINOGENESIS; CHEMICAL REACTION; CHROMOSOME DAMAGE; EPIDEMIOLOGICAL DATA; FOLLOW UP; GENE MUTATION; GENOTOXICITY; HUMAN; HYDROLYSIS; IN VITRO STUDY; IN VIVO STUDY; OCCUPATIONAL ASTHMA; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; REACTION ANALYSIS; REVIEW;

EID: 0035209214     PISSN: 10408444     EISSN: None     Source Type: Journal    
DOI: 10.1080/20014091111974     Document Type: Review

References (119)

1. Isocyanates
2. Toluene diisocyanate
3. The development of an animal model for TDI asthma
4. Immunohistochemical detection of toluene diisocyanate (TDI) adducts in pulmonary tissue of guinea pigs following inhalation exposure
5. New aspects of isocyanate asthma
6. Isocyanates and lung disease: Experimental approaches to molecular mechanisms
7. Mechanisms and pathology of occupational asthma
8. Two-week inhalation toxicity of polymeric diphenylmethane-4,4′-diisocyanate (PMDI) in rats: Analysis of biochemical and morphological markers of early pulmonary response
9. Pathomechanisms and pathophysiology of isocyanate-induced diseases - Summary of present knowledge
10. Isocyanate-conjugated human lung epithelial cell proteins: A link between exposure and asthma?
11. Toluene diisocyanate colocalizes with tubulin on cilia of differentiated human airway epithelial cells
12. Neutrophil activation following TDI bronchial challenges to the airway secretion from subjects with TDI-induced asthma
13. Overview of diisocyanate occupational asthma
14. Respiratory effects of inhaled isocyanates
15. Respiratory and other hazards of isocyanates
16. Systemic reactions associated with polyisocyanate exposure
17. Cancer incidence and mortality in the Swedish polyurethane foam manufacturing industry
18. Incidence of cancer and exposure to toluene diisocyanate and methylene diphenyliisocyanate: A cohort based case-referent study in the polyurethane foam manifacturing industry
19. Mortality and cancer morbidity of production workers in the United Kingdon flexible polyurethane foam industry
20. Mortality of workers exposed to toluene diisocyanate in the polyurethane foam industry
21. Toluene diisocyanates
22. 4,4′-Methylenediphenyl diisocyanate and polymeric 4,4′-methylenediphenyl diisocyanate
23. IARC: 2,4- and 2,6-toluene diisocyanates, 1,5-naphtalene diisocyanate, 4,4′-methylendiphenyl diisocyanate and polymethylene polyphenyl isocyanate and flexible and rigid polyurethane foams
24. Long term toxicity and carcinogenicity studies of commercial grade 2,4/2,6-toluene diisocyanate (80/20) in rats and mice
25. Toluene diisocyanate inhalation toxicity: Pathology and mortality
26. 14C during and following inhalation exposure to radioactive toluene diisocyanate
27. The carcinogenic activity of commercial-grade toluene diisocyanate in rats and mice in relation to the metabolism of 2,4- and 2,6-TDI isomers
28. Toluene diisocyanate: An assessment of carcinogenic risk following oral and inhalation exposure
29. Acute, subacute, and subchronic inhalation toxicity studies of respirable polymeric methylene diphenyl diisocyanate (polymeric MDI) areosol in rats
30. Chronic inhalation toxicity and carcinogenicity study of respirable polymeric methylene diphenyl diisocyanate (polymeric MDI) aerosol in rats
31. Biomonitoring of workers exposed to 4,4′-methylenedianiline or 4,4′methylenediphenyl diisocyanate
32. Albumin adducts, hemoglobin adducts and urinary metabolites in workers exposed to 4,4′-methylenediphenyl diisocyanate
33. Hemoglobin adducts and urine metabolites of 4,4′-methylenedianiline after 4,4′-methylenediphenyl diisocyanate exposure to rats
34. Mutagenic action of isocyanates used in the production of polyurethanes
35. Appendix II. The bacterial mutation test
36. Responses of the L5178Y mouse lymphoma cell forward mutation assay, V: 27 coded chemicals
37. Chromosome aberrations and sister-chromatid exchanges induced by technical grade toluene diisocyanate and methylenediphenyl diisocyanate in cultured human lymphocytes
38. Chromosome aberration and sister chromatid exchange test in Chinese hamster ovary cells in vitro
39. Effect of pretreatment with hepatic mixed-function oxidase inducers on the genotoxicity of four rat carcinogens in the hepatocyte/DNA repair assay
40. Chemical mutagenesis testing in Drosophila
41. Salmonella mutagenicity test
42. Studies on the effect of the solvents dimethylsufoxide and ethyleneglycoldimethylether on the mutagenicity of four types of diisocyanates in the Salmonella/microsome test
43. Chemical behaviour of seven aromatic diisocyanates and diphenylmethanediisocyanates under in vitro conditions in relationship to their results in the Salmonella/microsome test
44. Mutagenicity assessment of airborne particles from three polyurethane foam manufacturing facilities
45. Mutagenicity assessment of airborne particles from three polyurethane foam manufacturing facilities
46. Comparison among five mutagenicity assay in workers producing polyurethane foams
47. Mutagenicity of 4,4′-methylenedianiline derivatives in the Salmonella histidine reversion assay
48. Chemicals and cancer in humans: First evidence in experimental animals
49. Carcinogenesis, studies of 4,4′-methylenedianiline dihydrochloride given in drinking water to F344/N rats and B6C3F1 mice
50. Review of the genotoxicity and carcinogenicity of 4,4′-methylenedianiline and 4,4′-methylene-bis-2-chloroaniline
51. The reaction of phenyl isocyanate with purines, pyrimidines and deoxyribonucleic acid
52. Isolation of methylcarbamoyl-adducts of adenine and cytosine following in vitro reaction of methyl isocyanate with calf thymus DNA
53. Characterization and genotoxicity of DNA adducts caused by 2-naphthyl isocyanate
54. Selective reactivities of isocyanates towards DNA bases and genotoxicity of methylcarbamoylation of DNA
55. Studies on polynucleotides
56. Indication of DNA strand breaks in human white blood cells after in vitro exposure to toluene diisocyanate (TDI)
57. DNA double-strand breaks and apoptosis after in vitro exposure to toluene diisocyanate
58. Comparison of the binding potential of various diisocyanates on DNA in vitro
59. Distribution and DNA adduct formation of radiolabeled methylenediphenyl 4,4′-diisocyanate (MDI) in the rat after topical treatment
60. 32P-postlabeling analysis of DNA adducts formed in vitro and in rat skin by methylenediphenyl- 4,4′-diisocyanate (MDI)
61. In vivo and in vitro reactions of toluene diisocyanate isomers with guinea pig hemoglobin
62. Increased incidence of anti-dsDNA autoantibody concentration in sera of workers occupationally exposed to diisocyanates
63. 32P-postlabeling of a DNA adduct derived from 4,4′-methylenedianiline in the olfactory epithelium of rats exposed by inhalation to 4,4′-methylenediphenyl diisocyanate
64. DNA damage in human white blood cells after inhalative exposure to methylenediphenyl diisocyanate (MDI) - Case report
65. Investigation of the induction of DNA double-strand breaks by methylenediphenyl-4,4′-diisocyanate in cultured human lung epithelial cells
66. Covalent interactions of toluenediisocyanate with DNA and proteins
67. 14C]toluene 2,4-diamine in Fischer 344 rats
68. 14C-labeled toluene diisocyanate (TDI) in rats
69. Hemoglobin and DNA adduct formation in Fischer-344 rats exposed to 2,4- and 2,6-toluenediamine
70. Metabolic activation and DNA adducts of aromatic amines and nitroaromatic hydrocarbons
71. Assessment of exposure and susceptibility to aromatic amine carcinogens
72. Biotransformation of methyl isocyanate in the rat. Evidence for glutathione conjugation as a major pathway of metabolism and implications for isocyanate-mediated toxicities
73. Synthesis and quantification of DNA adducts of 4,4′-methylenedianiline
74. Hemoglobin binding of bicyclic aromatic amines
75. Determination of hemoglobin adducts of arylamines in humans
76. Comparison of hemoglobin binding, mutagenicity and carcinogenicity of arylamines and nitroarenes
77. Molecular dosimetry of aromatic amines in human populations
78. Electrophilic intermediate in the reaction of glutathione and nitrosoarenes
79. Reactions of nitrosoarenes with SH groups
80. Determination of occupational exposure to toluene diisocyanate by biological monitoring
81. Biomarkers in hydrolysed urine, plasma and erythrocytes among workers exposed to thermal degradation products from toluene diisocyanate foam
82. Albumin adducts in plasma from workers exposed to toluene diisocyanate
83. Toxicokinetics of 2,4- and 2,6-toluenediamine in hydrolysed urine and plasma after occupational exposure to 2,4- and 2,6-toluene diisocyanate
84. MDA in plasma as a biomarker of exposure to pyrolyzed MDI-based polyureathane; correlations with estimated cumulative dose and genotype for N-acetylation
85. Exposure biomarkers and risk from gluing and heating of polyurethane: A cross sectional study of respiratory symptoms
86. Untersuchungen zur internen Beanspruchung bei der Verarbeitung Isocyanathaltiger Produkte im Tiefbau
87. Deutsche Forschungsgemeinschaft Luftanalysen
88. Arylamine N-acetyltransferase in erythrocytes of cystic fibrosis patients
89. Exposure to toluene diamines from polyurethane-coated breast implants
90. Biological monitoring of occupational exposure to toluene diisocyanate: Measurement of toluenediamine in hydrolysed urine and plasma by gas chromatography-mass spectrometry
91. Biological monitoring of occupational exposure to toluene diisocyanate
92. Chromatographic determination of amines in biological fluids with special reference to the biological monitoring of isocyanates and amines
93. Biological monitoring of isocyanate and related amines
94. Monitoring of haemoglobin-methyl isocyanate adduct by high-performance liquid chromatography with diode array detector
95. Isocyanate-specific hemoglobin adduct in rats exposed to 4,4′-methylenediphenyl diisocyanate
96. 2,4-toluenediisocyanate and hexamethylene-diisocyanate adducts with blood proteins: Assessment of reactivity of amino acid residues in vitro
97. Synthesis and spectroscopic characterization of 4-chlorophenyl isocyanate (= 1-chloro-4-isocyanatobenzene) adducts with amino acids as potential dosimeters for the biomonitoring of isocyanate exposure
98. Reactions of 4-methylphenyl isocyanate with amino acids
99. Hemoglobin adducts of tobacco-related aromatic amines: Application to molecular epidemiology
100. Ranking possible carcinogenic hazards
101. Rodent carcinogens: Setting priorities
102. The fifth plot of the carcinogenic potency database: Results of animal bioassays published in the general literature through 1988 and by the National Toxicology Program through 1989
103. Biomonitoring of workers exposed to arylamines
104. Comparison of the metabolism of 2,4-toluenediamine in rats and mice
105. 1 in vivo in rats
106. Safety of polyurethane-covered, breast implants
107. Determination of human exposure to mycotoxins